Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Hologic, Inc.
Ruling keeps the principle of assignor estoppel in place, but restricts its use to situations where an inventor’s claims in court directly contradict those in the patent.
The ruling keeps the principle of assignor estoppel in place, but limits its use to situations where an inventor’s claims in court directly contradict those in the patent.
Akebia brings in Cyclerion’s diabetes candidate praliciguat, plus deals involving Genmab/Bolt, Auris/Trasir, Zymergen/Lodo, Bavarian Nordic/Dynavax and more.
PerkinElmer will add chemiluminescence products in endocrinology, autoimmunity and diagnostics to its portfolio with the planned buyout of Immunodiagnostics.
- Contract Research Organization-CRO
- In Vitro Diagnostics
- Laboratory Testing Services
Diagnostic Imaging Equipment & Supplies
- Digital Imaging
- Diagnostic Imaging Equipment & Supplies
- Other Names / Subsidiaries
- Acessa Health Inc.
- Biotheranostics, Inc.
- Cytyc Corporation
- Faxitron Bioptics, LLC
- Focal Therapeutics, Inc.
- Gen-Probe Inc.
- Interlace Medical Inc.
- Palomar Medical Techologies
- SuperSonic Imagine
- Third Wave Technologies
- SOMATEX Medical Technologies GmbH